The Department of Pharmaceuticals announced on 17 October 2026 that the National Pharmaceutical Pricing Authority (NPPA) has capped trade margins at 30% for 137 non-scheduled anti-cancer drugs. This measure is expected to reduce the Maximum Retail Price (MRP) of these medicines by up to 70%. The revised prices take effect from 9 November 2026. Manufacturers, hospitals, and retailers must implement these lower prices and display them on their websites and in pharmacies.
Key points
- MRP of 137 anti-cancer drugs may drop by up to 70%
- Trade margins capped at 30% of the Maximum Retail Price (MRP)
- Revised prices effective from 9 November 2026
- Manufacturers must notify NPPA of new prices within 7 days of the Gazette notification
- Consumers can check prices via the Pharma Sahi Daam app or NPPA website
When it applies
Counted from publication of the Gazette notification, dated 17 October 2026.
- Revised prices for anti-cancer drugs
- Within 7 days manufacturers to inform NPPA of revised prices
Who it affects
- patients and families affected by cancer
Refers to
- Drugs (Prices Control) Order (DPCO), 2013